Fibrotic and interstitial lung disease
Clinical research includes idiopathic pulmonary fibrosis and lung involvement linked to diffuse cutaneous systemic sclerosis, with attention to respiratory function and disease-related decline.
- Idiopathic pulmonary fibrosis
- Forced vital capacity
- Systemic sclerosis-associated lung disease
The sponsor’s portfolio reflects interest in conditions where pulmonary fibrosis and connective tissue disease overlap.
Autoimmune neurology
Research activity covers neuromyelitis optica spectrum disorder in children and adolescents, as well as myasthenia gravis associated with acetylcholine receptor antibodies or muscle-specific kinase antibodies.
- Neuromyelitis optica spectrum disorder
- Myasthenia gravis
- Autoantibody-mediated disease
These studies focus on immune-mediated disorders affecting the central nervous system and neuromuscular junction.
Systemic autoimmune connective tissue disease
The sponsor funds studies in diffuse cutaneous systemic sclerosis, primary discoid lupus erythematosus, and Sjögren’s syndrome, including forms with moderate-to-severe systemic disease activity.
- Diffuse cutaneous systemic sclerosis
- Primary discoid lupus erythematosus
- Sjögren’s syndrome
Clinical interests extend to both organ-based manifestations and patient-reported symptom burden in chronic autoimmune disease.
IgG4-related and B-cell mediated disease
Trials address immunoglobulin G4-related disease, a systemic inflammatory condition with relapsing activity and multi-organ involvement.
- IgG4-related disease
- Disease flare prevention
- Immune-mediated systemic inflammation
This area adds to the sponsor’s focus on antibody-associated autoimmune disorders and long-term control of inflammatory disease activity.
